IGM Biosciences (IGMS) Stock Highlights

16.65 | -5.83%

2024-09-19 03:54:53

IGM Biosciences Inc is a biotechnology company engaged in the development of IgM antibody therapeutics for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. Its IgM antibody technology platform is suited for developing T cell engagers, receptor cross-linking agonists, and targeted cytokines. Its product candidate, IGM-2323, is a bispecific T cell engaging IgM antibody targeting CD20 and CD3 protein, IGM-8444, a combination with a chemotherapeutic agent such as irinotecan, gemcitabine, or venetoclax, and IGM-7354, a bispecific IgM antibody delivering interleukin-15 (IL-15) cytokines to PD-L1 expressing cells for the treatment of patients with solid and hematologic malignancies.

Statistics

Range Today

15.24 18.32

Volume Today 464.7K

Range 1 Year

3.81 22.5

Volume 1 Year 79.94M

Range 3 Year

3.81 76.2

Volume 3 Year 265.34M

Range 10 Year

3.81 133

Volume 10 Year 350.7M

Highlights

Market Capitalization 729.62M (small)

Floating Shares 11.77M

Current Price 16.65

Price To Earnings -3.2

Price To Revenue 176.09

Price To Book 5.96

Earnings Per Share -3.57

Payout Ratio 0%

Performance

Latest -5.83%

1 Month +81.97%

3 Months +127.46%

6 Months +58.72%

1 Year +126.84%

3 Years -77.21%

5 Years -9.07%

10 Years -9.07%

Benchmarks

Market Capitalization

137 / 368

Gross Profits

130 / 278

Total Revenue

225 / 300

Total Rank

149 / 368

Free Cashflow

301 / 352

Performance 5 years

172 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.